Claire Petzinger, PA
Physician Assistant · Bend, ORNPI 1740839166
Payments from drug & device makers
Across 82 payments — averaging $17.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$731
- Teva Pharmaceuticals USA, Inc.$132
- Argenx US, Inc.$95
- Neurocrine Biosciences, Inc.$69
- Pfizer$56
- Lilly USA, LLC$54
- plus $278 from 13 others
What the payments were for
- Food & beverage$1,31993%
- Education$977%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 48 | $731 |
| Teva Pharmaceuticals USA, Inc. | 7 | $132 |
| Argenx US, Inc. | 4 | $95 |
| Neurocrine Biosciences, Inc. | 4 | $69 |
| Pfizer | 3 | $56 |
| Lilly USA, LLC | 2 | $54 |
| Genentech USA, Inc. | 1 | $37 |
| SK Life Science, Inc. | 2 | $30 |
| UCB, Inc. | 1 | $28 |
| Impel Pharmaceuticals Inc. | 1 | $24 |
| TG Therapeutics, Inc. | 1 | $20 |
| Amgen | 1 | $20 |
| Acadia Pharmaceuticals Inc | 1 | $19 |
| Medtronic | 1 | $19 |
| Cala Health, Inc. | 1 | $18 |
| Integra Lifesciences Corporation | 1 | $17 |
| Novartis | 1 | $16 |
| Merz Pharmaceuticals, LLC | 1 | $15 |
| Lundbeck LLC | 1 | $15 |
How this compares
$1,415 in reported general payments places this provider in the 85th percentile of 1,756 physician assistant providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Memantine Hcl | 70 | $1,369 |
| Oxcarbazepine | 17 | $859 |
| Levetiracetam | 28 | $523 |
| Donepezil Hcl | 38 | $493 |
| Sumatriptan Succinate | 28 | $358 |
| Topiramate | 42 | $347 |
| RizatriptanRizatriptan Benzoate | 19 | $237 |
| Lamotrigine | 16 | $194 |
| Escitalopram Oxalate | 20 | $163 |
| Nortriptyline Hcl | 20 | $149 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 14 | $140 |
| Amitriptyline Hcl | 11 | $123 |
| Prednisone | 11 | $119 |
| Quetiapine Fumarate | 11 | $39 |
| Sertraline Hcl | 12 | $33 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Bend
- Hanna TynerBend$12K
- Katie LahusenBend$9K
- Sarah AtkinBend$7K
- Tara HardingeBend$6K
- Rainie RogersBend$6K
- Kirsten HeronBend$5K
- Devon ParksEugene$62K
- Ryan CainCorvallis$55K
- Sean BrownPortland$43K
- Pooja PatelWoodburn$41K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.